TG Therapeutics Inc

NASDAQ:TGTX  
34.27
+0.03 (+0.09%)
Regulatory, Equity Financing / Related, Initial Public Offerings

Tg Therapeutics Announces Proposed Public Offering Of Common Stock

Published: 12/14/2020 14:21 GMT
TG Therapeutics Inc (TGTX) - Tg Therapeutics Announces Proposed Public Offering of Common Stock.
Tg Therapeutics Inc Says Commences Underwritten Public Offering of $200.0 Million of Common Stock.
Tg Therapeutics Inc Says Intends to Use Net Proceeds of Public Offering to Fund Continued Development of Ublituximab and Umbralisib.